Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Go back to Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Tandem Diabetes (TNDM) Misses Q3 EPS, Revenue; Guides Lower

November 2, 2022 4:16 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.76), which may not compare to the analyst estimate of ($0.05). Revenue for the quarter came in at $204.55 million versus the consensus estimate of $207.56 million.

GUIDANCE:

Tandem Diabetes sees Q4 2022 revenue of $800-805 million, versus... More